RX TSXV · Healthcare · FY 2025-12-31
BioSyent Inc.
ABV
EPV
EBV
DBV
fair value / share
buy at or below (margin of safety applied)
margin-of-safety band
current price
values in CAD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Franchise
Confidence
●●●
High · 4/4
Price
14.750 CAD
Market cap
166.1M CAD
P / B
4.01
P / E
18.43
EPS
0.800
DPS / yield
0.210 (1.4%)
NAV / share
3.256
Graham number
8.141
Z'' score
13.68
Piotroski F
6 / 9
Beneish M
-2.29
ROIC vs WACC
44.1%
vs 8.6%
See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.
Subscribe to unlock this and every other tab for every company.
See the full ABV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EPV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full DBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.